Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore the value of credit card points when converted to cash to maximize your returns. Learn how to make your points work for you.
25,460 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Amazon shares navigate a shifting tech landscape in 2026 as analysts map a path from near-term growth to a longer-ter...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
A $130,000 insider sale at CorVel raises questions for investors. This guide breaks down what the move could mean, ho...
A little-known AI infrastructure stock last year exploded 14x, shaking up investors who focus on AI chips. This artic...
In April, nebius group stock popped as investors weighed cloud and AI catalysts. This piece breaks down the drivers, ...
Investors are watching FIGS as the stock shows signs of momentum. This article breaks down the reasons behind figs st...
Apple signals a strategic pivot, moving its flagship away from the iPhone toward ambient computing with Vision Pro an...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...
Despite fintech rivals, Western Union remains a durable money-movement platform with a vast network and steady cash f...
Investors are always on the hunt for the next big winner. When a software stock looks beaten-down, opportunities and ...
Berkshire Hathaway faces a pivotal July 22 shareholder vote on a major housing bet. This deep dive explains what’s at...